You just read:

AbbVie Receives CHMP Positive Opinion for VENCLYXTO™ (venetoclax) Tablets for Appropriate Patients with Difficult-To-Treat Chronic Lymphocytic Leukaemia

News provided by

AbbVie

14 Oct, 2016, 12:26 BST